180 Life Sciences Corp/$ATNF
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About 180 Life Sciences Corp
180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.
Ticker
$ATNF
Sector
Primary listing
Industry
Biotechnology
Headquarters
Employees
4
ISIN
US68236V3024
Website
ATNF Metrics
BasicAdvanced
$4.6M
-
-$9.43
0.24
-
Price and volume
Market cap
$4.6M
Beta
0.24
52-week high
$1.47
52-week low
$0.66
Average daily volume
45K
Financial strength
Current ratio
1.022
Quick ratio
0.947
Long term debt to equity
0.044
Total debt to equity
1.97
Interest coverage (TTM)
-179.27%
Profitability
EBITDA (TTM)
-6.556
Effective tax rate (TTM)
3.81%
Management effectiveness
Return on assets (TTM)
-54.71%
Return on equity (TTM)
-221.23%
Valuation
Price to book
0.54
Price to tangible book (TTM)
49.65
Price to free cash flow (TTM)
-1.009
Free cash flow yield (TTM)
-99.15%
Free cash flow per share (TTM)
-79.29%
Growth
Earnings per share change (TTM)
-71.58%
3-year earnings per share growth (CAGR)
-31.70%
ATNF News
AllArticlesVideos
180 Life Sciences Corp. Announces Strengthening of Legacy Intellectual Property Assets
Accesswire·1 week ago
180 Life Sciences Corp. Announces Notice of Allowance for U.S. Patent Covering Novel Method to Prevent or Reduce Post-Operative Cognitive Dysfunction
Accesswire·2 months ago
180 Life Sciences Corp. Announces Share Repurchase
Accesswire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for 180 Life Sciences Corp stock?
180 Life Sciences Corp (ATNF) has a market cap of $4.6M as of July 09, 2025.
What is the P/E ratio for 180 Life Sciences Corp stock?
The price to earnings (P/E) ratio for 180 Life Sciences Corp (ATNF) stock is 0 as of July 09, 2025.
Does 180 Life Sciences Corp stock pay dividends?
No, 180 Life Sciences Corp (ATNF) stock does not pay dividends to its shareholders as of July 09, 2025.
When is the next 180 Life Sciences Corp dividend payment date?
180 Life Sciences Corp (ATNF) stock does not pay dividends to its shareholders.
What is the beta indicator for 180 Life Sciences Corp?
180 Life Sciences Corp (ATNF) has a beta rating of 0.24. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.